Navigation

Investiment.io
Financial analysis platform

AbbVie Inc.

ABBV โ€ข NYSE

$294.55
โ–ผ0.48 (0.16%)โ€ข REGULAR

AbbVie Inc.

$294.55
โ–ผ0.2%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
๐Ÿ’ผ

Earnings for ABBV

Quarterly earnings call history, sourced from SEC filings

View Transcripts
QuarterDate
Q3 2026October 30, 2026View Transcript โ†’
Q2 2026July 31, 2026View Transcript โ†’
Q1 2026April 29, 2026View Transcript โ†’
Q4 2025February 4, 2026View Transcript โ†’
Q3 2025October 31, 2025View Transcript โ†’
Q2 2025July 31, 2025View Transcript โ†’
Q1 2025April 25, 2025View Transcript โ†’
Q4 2024January 31, 2025View Transcript โ†’
Q3 2024October 30, 2024View Transcript โ†’
Q2 2024July 25, 2024View Transcript โ†’
Q1 2024April 26, 2024View Transcript โ†’
Q4 2023February 2, 2024View Transcript โ†’
Q3 2023October 27, 2023View Transcript โ†’
Q2 2023July 27, 2023View Transcript โ†’
Q1 2023April 27, 2023View Transcript โ†’
Q4 2022February 9, 2023View Transcript โ†’
Q3 2022October 28, 2022View Transcript โ†’
Q2 2022July 29, 2022View Transcript โ†’
Q1 2022April 29, 2022View Transcript โ†’
Q4 2021February 2, 2022View Transcript โ†’
Q3 2021October 29, 2021View Transcript โ†’
Q2 2021July 30, 2021View Transcript โ†’
Q1 2021April 30, 2021View Transcript โ†’
Q4 2020February 3, 2021View Transcript โ†’
Q3 2020October 30, 2020View Transcript โ†’
Q2 2020July 31, 2020View Transcript โ†’
Q1 2020May 1, 2020View Transcript โ†’
Data sourced from SEC filings via Equibles